http://orcid.org/0000-0002-3213-7373
Figures
Abstract
This is a prospective study to establish prediction models that map the refined Scoliosis Research Society 22-item (SRS-22r) onto EuroQoL-5 dimension 5-level (EQ-5D-5L) utility scores in adolescent idiopathic scoliosis (AIS) patients. Comparison of treatment outcomes in AIS can be determined by cost-utility analysis. However, the mainstay spine-specific health-related quality of life outcome measure, the SRS-22r questionnaire does not provide utility assessment. In this study, AIS patients were prospectively recruited to complete both the EQ-5D-5L and SRS-22r questionnaires by trained interviewers. Ordinary least squares regression was undertaken to develop mapping models, which the validity and robustness were assessed by using the 10-fold cross-validation procedure. EQ-5D-5L utility scores were regressed on demographics, Cobb angle, curve types, treatment modalities, and five domains of the SRS-22r questionnaire. Three models were developed using stepwise selection method. EQ-5D-5L scores were regressed on 1) main effects of SRS-22r subscale scores, 2) as per 1 plus squared and interaction terms, and 3) as per 2 plus demographic and clinical characteristics. Model goodness-of-fit was assessed using R-square, adjusted R-square, and information criteria; whereas the predictive performance was evaluated using root mean square error (RMSE), mean absolute error (MAE), and the proportion of absolute error within the threshold of 0.05 and 0.10. A total of 227 AIS patients with mean age of 15.6 years were recruited. The EQ-5D-5L scores were predicted by four domains of SRS-22r (main effects of ‘Function’, ‘Pain’, ‘Appearance’ and ‘Mental Health’, and squared term of ‘Function’ and ‘Pain’), and Cobb angle in Model 3 with the best goodness-of-fit (R-square/adjusted R-square: 62.1%/60.9%). Three models demonstrated an acceptance predictive performance in error analysis applying 10-fold cross-validation to three models where RMSE and MAE were between 0.063–0.065 and between 0.039–0.044, respectively. Model 3 was therefore recommended out of three mapping models established in this paper. To our knowledge, this is the first study to map a spine-specific health-related quality of life measure onto EQ-5D-5L for AIS patients. With the consideration and incorporation of demographic and clinical characteristics, over 60% variance explained by mapping model 3 enabled the satisfactory prediction of EQ-5D-5L utility scores from existing SRS-22r data for health economic appraisal of different treatment options.
Citation: Wong CKH, Cheung PWH, Samartzis D, Luk KD-K, Cheung KMC, Lam CLK, et al. (2017) Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis. PLoS ONE 12(4): e0175847. https://doi.org/10.1371/journal.pone.0175847
Editor: Chun Kee Chung, Seoul National University College of Medicine, REPUBLIC OF KOREA
Received: November 24, 2016; Accepted: March 31, 2017; Published: April 17, 2017
Copyright: © 2017 Wong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis, representing structural curves detected during adolescence without any clear underlying cause.[1] This type of scoliosis accounts for, up to 80% of idiopathic scoliosis in the United States, in otherwise healthy individuals undergoing puberty.[2] These patients often experience truncal imbalance, cosmetic unsightliness and even back pain with associated reduction in physical and mental health.[3–5] In severe cases, cardiopulmonary compromise may occur.[6, 7] These presentations in addition to curve progression may lead to a worsened impact on patients’ health-related quality of life (HRQoL) as a whole. The latest version of Scoliosis Research Society (SRS) instruments, the Refined Scoliosis Research Society 22-item (SRS-22r) questionnaire[8], is adopted to capture the HRQoL of AIS patients. The SRS-22r has been shown as a valid and reliable tool which has been used extensively over the past decade. From a recent systematic review of studies reporting quality of life, the most frequently used instruments were Scoliosis Research Society 22-item, 30-item and 24-item (SRS-22, SRS-30, SRS-24) questionnaires, contributing to approximately three-fourth of the reviewed studies.[9]
For AIS management, bracing is usually offered for moderate-sized progressive curves and surgery is offered for severe curvatures of over 40–45°.[4, 10] With increased disease prevalence and economic burden imposed to the healthcare system, evidence regarding cost-utility becomes an essential component for critical appraisal of available treatment options. Among those with curves between 35° to 55°, there is controversy upon which whether observation, bracing or surgery is better indicated in the context of cost-utility or HRQoL.[11, 12] Differentiating treatment options such as surgical approaches, implant strategy and instrumentation systems with regards to cost-utility is also necessary. As such, little is known to elucidate the health economic values of AIS treatment modalities.
As utility score data is an essential input for quality-adjusted life-years (QALYs) calculation in cost-utility analysis,[13] there is a need to develop an algorithm that maps HRQoL scores from scoliosis-specific instrument onto utility scores. Despite the good correlation between SRS-22 and generic 36-Item Short Form Health Survey (SF-36) questionnaires, the existing mapping model available for predicting SRS-22 subscale scores from SF-36 subscale scores for AIS patients is in the mental health and pain domains only.[14] In search of a more appropriate measure specifically for AIS, the EuroQol-5 Dimension (EQ-5D) utility score has been used in all economic evaluation submitted to health technology assessment authorities such as the National Institute for Health and Care Excellence (NICE) in UK.[15] This goes beyond ethnic and cultural background as the EuroQol-5 Dimension 5-Level (EQ-5D-5L) utility score has been shown to be a valid, reliable and sensitive measure to assess the HRQoL in southern Chinese AIS patients. The EQ-5D-5L utility score showed good and significant correlations with SRS-22r total and all domain scores except for Satisfaction with Management.[16] Therefore this study aims to establish a prediction model that maps spine-specific scores represented by the SRS-22r, onto the EQ-5D-5L utility scores in AIS patients, with adjustment for demographic and clinical characteristics. We hypothesized that the Satisfaction with Management domain will not be significant predictor of the EQ-5D-5L score because such domain is not conceptually included in any of the five domains of EQ-5D-5L.
Materials and methods
Subjects
A prospective study with recruitment of southern Chinese AIS patients managed at a tertiary referral center for scoliosis during the months of August to October 2015 was performed. Exclusion criteria included patients with non-idiopathic scoliosis, those who could not understand traditional Chinese, with intellectual/ physical disability, or refused to participate. Ethics approval was obtained from the local Institutional Review Board of the University of Hong Kong / Hospital Authority Hong Kong West Cluster (HKWC/HKU IRB). Written informed consent was obtained from all recruited patients and the consent document was approved by the ethics committee. The reporting of this mapping study complied with the Mapping onto Preference-based measures reporting Standards (MAPS) statement.[17]
All eligible patients were approached by trained research personnel who distributed and allowed self-completion of both the EQ-5D-5L (Hong Kong (traditional Chinese) EQ-5D-5L Version 1.0, EuroQol)[18] and SRS-22r questionnaires.[19] To control for the ordering effect of completing the questionnaire, half of the patients were provided with EQ-5D-5L followed by SRS-22r, and the remaining half were given the questionnaires in the reversed order. All questionnaires were completed by the patients themselves.
During the visit, patients’ consultation and radiographic examinations were performed as usual. A spine surgeon measured the Cobb angle[20] on the standing whole spine posteroanterior radiograph taken at that appointment without any knowledge of this study. The curvatures were classified subsequently using the modified Lenke classification system,[21] which included six curve types: type 1 (main thoracic), type 2 (double thoracic), type 3 (double major; thoracic curve larger than lumbar curve), type 4 (triple major), type 5 (thoracolumbar or lumbar curve), type 6 (double major; thoracolumbar or lumbar curve larger than thoracic curve), and curvature magnitude (≤40° vs >40°) was noted. Clinical parameters also included treatment modalities of whether the patient had bracing or surgery, and the duration of bracing (<1 year vs ≥1 year) if applicable. Demographic data such as age and sex were collected.
Study instruments
Refined Scoliosis Research Society 22-item (SRS-22r).
The SRS-22r questionnaire, a refinement of the SRS-24 questionnaire, was a disease-specific instrument used routinely during management of scoliosis patients. It had been previously validated in the Hong Kong Chinese scoliosis population.[19] It contained 22 items contributing to five main domains: Function (5 items), Pain (5 items), Self-image/appearance (5 items), Mental Health (5 items), Satisfaction with Treatment (Current/Previously performed—2 items).
EuroQoL 5-dimension 5-level (EQ-5D-5L).
The EQ-5D-5L is the latest version of the EQ-5D multi-attribute health classification system for measuring HRQOL and utility scores, consisting of five dimensions: mobility, self-care, usual activity, pain/discomfort and anxiety/depression. Each dimension had five severity levels: no problem, mild problem, moderate problems, severe problems, extreme problems. In principle, the utility scores are preference weights measured on a cardinal scale of 0–1, where ‘0’ indicates death and 1 indicates perfect health. Health states worse than death takes negative value of utility. Since the Chinese-specific EQ-5D-5L value set was currently unavailable, the EQ-5D-5L utility score was not determined through direct valuation of EQ-5D-5L health states. Rather, the two-step indirect approach was applied in this study to estimate EQ-5D-5L values applicable for Chinese population, as adopted in previous studies.[22, 23] The first step was the application of an indirect interim mapping method from a six-country study coordinated by EuroQoL group.[24] The EQ-5D-5L health status was transformed to EQ-5D-3L health status following the transition probabilities between the response patterns of EQ-5D-5L and EQ-5D-3L. Finally, EQ-5D-3L health status were scored according to a recently developed Chinese-specific EQ-5D-3L value set ranging from -0.149 for the worst health status (‘33333’) to 1 for the full health (‘11111’).[25]
Statistical analysis
Model specification.
Three separate models (Table 1) mapping SRS-22r onto EQ-5D-5L utility score were estimated by ordinary least squares (OLS) method. EQ-5D-5L scores were regressed on 1) five main terms (Function / Pain / Appearance / Mental Health / Satisfaction with Treatment) of SRS-22r subscale scores (Model 1), 2) as per 1 plus squared terms of subscale scores selected in Model 1 (Model 2), and 3) as per 2 plus demographic and clinical characteristics such as Cobb angle and treatment modalities (Model 3). Squared terms were added to the mapping function to account for possible non-linear association between SRS-22r and EQ-5D-5L utility score. The OLS method was the commonest estimation method, accounting for 80% of studies mapping HRQOL scores onto EQ-5D scores[26]. Backward stepwise selection approach was used to select an array of variables in each model. The F-test was used to retain variables with an exclusion criterion of P-value greater than 0.10. There was a total of three mapping models developed for researchers to decide which mapping model was chosen depending upon the availability of demographic and clinical data.
Model validation and comparison.
Model validation of three mapping functions were assessed by using the 10-fold cross-validation procedure.[27, 28] In brief, our sample is randomly partitioned into 10 equally sized subsamples. Of the 10 subsamples, one subsample and nine remaining subsamples were used as training and validation data, respectively. The cross-validation procedure was repeated 10 times with each of the nine subsamples (204–205 samples each) used once as the validation data. The model parameters, goodness-of-fit and predictive performances from the 10 folds were averaged to produce a single estimation.
Model goodness-of-fit was assessed using R-square, adjusted R-square, Akaike information criteria (AIC), and Bayesian information criteria (BIC) statistics. A better model goodness-of-fit was indicated if the R-square and adjusted R-square were higher; and the AIC and BIC values were lower. To assess the predictive performance of models, the differences between the predicted and observed EQ-5D-5L scores at individual level were examined by computing root mean square error (RMSE) and mean absolute error (MAE). The number of observations and the corresponding proportions in the sample where the absolute error (AE) was greater than 0.05 and 0.10, respectively, were calculated. The ranges of the achievable EQ-5D-5L scores from the resulting mapping models were compared with the theoretical range of the EQ-5D-5L scores computed according to Chinese-specific tariff.
All statistical analyses were conducted using the STATA software (StataCorp LP, College Station, Tex) version 13.0.
Results
A total of 227 AIS patients were recruited. A majority of patients were female (75%), with a mean age of 15.6 years (standard deviation (SD): 4.5). 33.1% of this studied population were undergoing bracing or had corrective surgery performed. The mean Cobb angle was 25.0 degrees (SD: 11.4 degrees) at recruitment (Table 2). Descriptive statistics of EQ-5D-5L utility scores and SRS-22r domain scores were found in Table 3. The mean EQ-5D-5L utility scores was 0.931 (SD: 0.113; range: 0.339–1.000).
The OLS regression analysis of the models and those validation results were shown in Table 4 and Table 5, respectively. Main effects of five domain scores of SRS-22r were the predictors of the first model (model 1) but ‘Satisfaction’ domain score was dropped due to statistical insignificance (P-value>0.01). In model 2, the squared terms of four remaining domains were added for consideration but only the squared term of ‘Function/activity’ and ‘Pain’ domain scores (P-value = 0.041; P-value = 0.022) remained significant during the stepwise selection procedure. Cobb angle at recruitment (P-value<0.01) were retained in model 3 when adjusting for all demographic and clinical characteristics. By using ordinary least square estimation with clinical and demographic characteristics, EQ-5D-5L score was regressed on SRS-22r Domain scores with detailed formula equation of the selected model 3 found as expressed below:
Model 2 and 3 got R-square of 60% or above, demonstrating acceptable goodness-of-fit. The R-square, adjusted R-square, AIC and BIC values were further improved and optimized with adjustment of patients’ characteristics. Model 3 had better goodness-of-fit than Model 1 and 2. Predictive performance was considered good according to the error analysis and excellent values as expressed in terms of RMSE and MAE (Table 4). The scatterplot of observed and predicted EQ-5D-5L scores by mapping function was shown in Fig 1. A pattern of overestimation was recognized for observed scores lower than 0.8, whereas underestimation was recognized for observed scores beyond 0.8. Table 5 depicted the predictive performance of three models in the 10-fold cross-validation. In error analysis using cross-validation, RMSE and MAE were between 0.063–0.065 and between 0.039–0.044, respectively. Validation results of applying mapping models to AIS patients ascertained that models predicted the EQ-5D-5L scores accurately. Therefore, model 3 was recommended out of three mapping models given that the SRS-22r subscale scores and Cobb angle were available.
There was overestimation for more severe health states when the observed EQ-5D-5L utility scores was smaller than 0.8. Underestimation was demonstrated for observed EQ-5D-5L utility scores beyond 0.8.
Discussion
AIS is the most common pediatric spinal deformity affecting both physical and mental health. Treatment options involving observation, bracing and surgeries can impose various degrees of burden onto patients.[5, 29–33] Such burdens can be induced by a concern of curvature progression depending on its initial magnitude and patients’ maturity status, aesthetic concern, inconvenience of bracing during daily activities, as well as postoperative pain, and recovery for surgical patients.[34, 35] It is demonstrated that AIS patients may experience psychosocial difficulties, especially those undergoing active treatment, as compared to adults with scoliosis, who generally display fewer psychological problems.[35] Hence the varied quality of life of AIS patients and their treatment outcome warrant an assessment, especially in terms of economic evaluation in relation to different treatment options.
The SRS-22r questionnaire, being a disease-specific measure, is able to assess states and concerns of this particular diagnostic groups, and may have more items concerning functions most relevant to the disease.[36] However, such an instrument does not give the utility score for comparison across different disease populations. Health state utility values are usually based on generic instruments that permit comparisons between patient groups.[37] Therefore, it is desirable to have an equivalent and widely used generic instrument, which is shown to be successful in capturing the spine-specific questionnaire responses from AIS patients. The EQ-5D is recommended and widely used in economic evaluation as required by the NICE.[38] It has been most widely applied in recent years[39] as the EQ-5D is cognitively simple for self-completion, and it is found to be the most commonly used instrument in most cost-utility analysis studies conducted alongside clinical trials.[40] NICE states that ‘when EQ-5D data are not available or are inappropriate for the condition or effects of treatment, the valuation methods should be fully described and comparable to those used for EQ-5D’.[38] In particular, EQ-5D-5L was shown to have improved measurement properties and discriminatory power with reduced ceiling effects as compared to EQ-5D-3L.[41] Hence, the mapping of SRS-22r responses onto EQ-5D-5L score is required to enable an economic evaluation of treatment outcomes of AIS patients.[42]
Regarding the pattern of overestimation for observed scores lower than 0.8, and underestimation for observed scores beyond 0.8, there is a lower likelihood of being overestimated by this mapping model because of ceiling effects of the EQ-5D-5L utility score. About two-third (66%) respondents had a perfect health state of EQ-5D-5L, and thus those utility scores with maximum score of 1.0 are impossible to be overestimated.
The development of our mapping model not only aims to establish statistical relationship between EQ-5D-5L utility scores and scoliosis-specific SRS-22r domain scores, it also explores the possibility of developing accurate but simple-to-use mapping models leveraging conversion from existing SRS-22r data onto EQ-5D utility scores. It is mandatory to further investigate the accuracy and reliability of such mapping models in their predictions for AIS, as well as to ascertain the models’ suitability for this particular scoliotic group. SRS-22r dimension scores therefore are mapped onto EQ-5D-5L scores using a number of different model specifications. The predictive performance and goodness-of-fit indices of mapping models for AIS are evaluated on a variety of treatment modalities, regardless of active observation, bracing or surgical intervention.
There are three models developed in our attempt to seek the ability of mapping SRS-22r onto EQ-5D-5L at its best extent. Notably, through the inclusion of not only the demographic profiles, but with the four out of five possible SRS domain scores captured (Function/activity, Pain, Self-image/Appearance, and Mental Health except Satisfaction with Treatment), the model has improved from the base model to demonstrate an acceptable goodness-of-fit. By further addition of socio-demographic characteristics like sex and age of patients, and explanatory variables such as Cobb angle at the time of presentation and treatment status, the final model continues to offer improved model performance with good predictive performance and a relatively constant MAE. The clinical relevance of this developed mapping model should be emphasized, as the Cobb angle at the time of visit, the squared terms of ‘Function/activity’ and ‘Pain’ domain scores were found to be significant. These are variables which clinicians can professionally assess and can find their relevance. Addition of squared terms of SRS-22r domains provided evidence on the non-linear associations between spine-specific HRQOL scores and health utility score. On the other hand, despite not being found at a significant level statistically, aspects like patients’ perceived appearance and mental health may not be easily gauged by clinicians, but they were successfully included in the development of this mapping model.
The main limitation of this study relates to the Hong Kong value sets of EQ-5D-5L currently not being available until further social tariff of EQ-5D is developed. As this study being the first to map between EQ-5D-5L and SRS-22r questionnaires and focused specifically onto the local Chinese scoliosis population, no existing mapping function is available for comparison, and the mapping models generated can be population-specific. It will be ideal to have comparative studies in other countries or ethnic groups, and variable health-care systems to further validate our findings. A larger scale multi-center study of Chinese scoliosis patients can be helpful to provide large sample sizes for further testing of the developed model. Also, it is worth mentioning that the domain of treatment satisfaction of SRS-22r is not covered by EQ-5D-5L. Self-image, as a disease-specific domain, is not included either in the EQ-5D-5L. However, the addition of clinical parameter based on Cobb angle is accounted for, hence the model is only slightly undermined with good resultant predictive performance and goodness of fit still.
Nonetheless, this is the first study to establish statistical models mapping a scoliosis-specific HRQoL questionnaire onto a widely used generic utility score specifically for AIS patients. Although there are currently no standards or thresholds of whether our mapping models are adequately performed, they out-performed most of the published mapping models[43] in terms of goodness-of-fit indices and predictive performance. The mapping process has been perfected by incorporating scoliosis-specific clinical and demographic characteristics into the model. Not only is the achieved mapping model feasible to be used in economic evaluation of clinical research projects, this valid model has provided the basis for the ultimate assessment of QALYs, a measure of health benefit enabling a standardized approach for comparing economic evaluations across different healthcare areas.[13, 39]
Conclusion
Being able to employ EQ-5L-5D through mapping based on existing SRS-22r data allows comparison of AIS with other populations or disease groups, and more importantly enables health economic appraisal for AIS patients, in terms of cost-utility of different treatment options, patients’ quality of life resulting from treatment undergone and their QALY. As the impact of a treatment on patients’ HRQoL and the impact on the length of life can both be encapsulated by QALY, a summary measure of health outcome can then be derived. Based on such health outcome, this will bring current assessment to a new phase in the aspect of clinical appraisal of different scoliosis centers, and orientate their management approach towards more effective use of resources. This can alter healthcare resource allocation decisions and can potentially reform healthcare policy on its largest scale. Moreover, this can bring a new perspective to the decision making on individual treatment option and management of AIS patients in the future.
Supporting information
S1 Dataset. Dataset used to generate the results of this study.
https://doi.org/10.1371/journal.pone.0175847.s001
(XLSX)
Author Contributions
- Conceptualization: JPYC KDL.
- Data curation: PWHC CKHW.
- Formal analysis: CKHW.
- Investigation: PWHC.
- Methodology: JPYC CKHW.
- Project administration: JPYC PWHC.
- Resources: KDL KMC CLKL.
- Supervision: JPYC.
- Validation: CKHW.
- Visualization: CKHW.
- Writing – original draft: JPYC PWHC CKHW.
- Writing – review & editing: JPYC CKHW PWHC DS KDL KMC CLKL.
References
- 1. Lonstein JE. Adolescent idiopathic scoliosis. Lancet. 1994;344(8934):1407–12. pmid:7968079
- 2. Riseborough EJ, Wynne-Davies R. A genetic survey of idiopathic scoliosis in Boston, Massachusetts. The Journal of bone and joint surgery American volume. 1973;55(5):974–82. Epub 1973/07/01. pmid:4760104
- 3. Ghandehari H, Mahabadi MA, Mahdavi SM, Shahsavaripour A, Seyed Tari HV, Safdari F. Evaluation of Patient Outcome and Satisfaction after Surgical Treatment of Adolescent Idiopathic Scoliosis Using Scoliosis Research Society-30. Archives of bone and joint surgery. 2015;3(2):109–13. Epub 2015/06/26. PubMed Central PMCID: PMCPmc4468625. pmid:26110177
- 4. Weinstein SL, Dolan LA, Spratt KF, Peterson KK, Spoonamore MJ, Ponseti IV. Health and function of patients with untreated idiopathic scoliosis: a 50-year natural history study. JAMA. 2003;289(5):559–67. pmid:12578488
- 5. Cheung KM, Cheng EY, Chan SC, Yeung KW, Luk KD. Outcome assessment of bracing in adolescent idiopathic scoliosis by the use of the SRS-22 questionnaire. International orthopaedics. 2007;31(4):507–11. Epub 2006/08/10. PubMed Central PMCID: PMCPmc2267629. pmid:16896864
- 6. Pehrsson K, Danielsson A, Nachemson A. Pulmonary function in adolescent idiopathic scoliosis: a 25 year follow up after surgery or start of brace treatment. Thorax. 2001;56(5):388–93. Epub 2001/04/20. PubMed Central PMCID: PMCPmc1746049. pmid:11312408
- 7. Huh S, Eun LY, Kim NK, Jung JW, Choi JY, Kim HS. Cardiopulmonary function and scoliosis severity in idiopathic scoliosis children. Korean journal of pediatrics. 2015;58(6):218–23. Epub 2015/07/28. PubMed Central PMCID: PMCPmc4510355. pmid:26213550
- 8. Asher MA, Lai SM, Glattes RC, Burton DC, Alanay A, Bago J. Refinement of the SRS-22 Health-Related Quality of Life questionnaire Function domain. Spine (Phila Pa 1976). 2006;31(5):593–7.
- 9. Cutler HS, Guzman JZ, Connolly J, Maaieh MA, Allen AK, Cho SK. Patient-Reported Outcome Instruments in Pediatric Deformity Surgery: A Bibliometric Analysis. Spine Deformity. 2015;3 (2):136–43 pmid:27927304
- 10. Weinstein SL, Dolan LA, Wright JG, Dobbs MB. Effects of bracing in adolescents with idiopathic scoliosis. The New England journal of medicine. 2013;369(16):1512–21. Epub 2013/09/21. PubMed Central PMCID: PMCPmc3913566. pmid:24047455
- 11. Telang SS, Suh SW, Song HR, Vaidya SV. A large adolescent idiopathic scoliosis curve in a skeletally immature patient: is early surgery the correct approach? Overview of available evidence. Journal of spinal disorders & techniques. 2006;19(7):534–40. Epub 2006/10/06.
- 12. Weiss HR. Adolescent idiopathic scoliosis (AIS)—an indication for surgery? A systematic review of the literature. Disability and rehabilitation. 2008;30(10):799–807. Epub 2008/04/25. pmid:18432438
- 13. Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. British medical bulletin. 2010;96:5–21. Epub 2010/11/03. pmid:21037243
- 14. Lai SM, Asher M, Burton D. Estimating SRS-22 quality of life measures with SF-36: application in idiopathic scoliosis. Spine. 2006;31(4):473–8. Epub 2006/02/17. pmid:16481961
- 15.
National Institute for Health and Clinical Excellence: Guide to the methods of technology appraisal 2013. 2013
- 16. Cheung PW, Wong CK, Samartzis D, Luk KD, Lam CL, Cheung KM, et al. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 2016;11:19. PubMed Central PMCID: PMCPMC4973368. pmid:27525314
- 17. Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, et al. Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. PharmacoEconomics. 2015;33(10):985–91. pmid:26232201
- 18. Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014;17(4):445–53. Epub 2014/06/28.
- 19. Cheung KM, Senkoylu A, Alanay A, Genc Y, Lau S, Luk KD. Reliability and concurrent validity of the adapted Chinese version of Scoliosis Research Society-22 (SRS-22) questionnaire. Spine (Phila Pa 1976). 2007;32(10):1141–5.
- 20.
Cobb J. Outline for the study of scoliosis. In: Blount WP, Banks SW, eds. The American Academy of Orthopaedic Surgeons Instructional Course Lectures 5th Ed Ann Arbor, MI: JW Edwards. 1948;(5th Ed. A;nn Arbor, MI: JW Edwards):261–75.
- 21. Lenke LG, Betz RR, Harms J, Bridwell KH, Clements DH, Lowe TG, et al. Adolescent idiopathic scoliosis: a new classification to determine extent of spinal arthrodesis. J Bone Joint Surg Am. 2001;83-A(8):1169–81. pmid:11507125
- 22. Pan CW, Sun HP, Wang X, Ma Q, Xu Y, Luo N, et al. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2015;24(7):1767–74. Epub 2014/12/30.
- 23. Pan CW, Sun HP, Zhou HJ, Ma Q, Xu Y, Luo N, et al. Valuing Health-Related Quality of Life in Type 2 Diabetes Patients in China. Medical decision making: an international journal of the Society for Medical Decision Making. 2016;36(2):234–41. Epub 2015/09/25.
- 24. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2012;15(5):708–15. Epub 2012/08/08.
- 25. Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014;17(5):597–604. Epub 2014/08/17.
- 26. Dakin H. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health and Quality of Life Outcomes. 2013;11:151. pmid:24010873
- 27. Wong CK, Lam CL, Rowen D, McGhee SM, Ma KP, Law WL, et al. Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm. Value Health. 2012;15(3):495–503. pmid:22583460
- 28. Wu EQ, Mulani P, Farrell MH, Sleep D. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value Health. 2007;10(5):408–14. pmid:17888106
- 29. Climent JM, Sanchez J. Impact of the type of brace on the quality of life of Adolescents with Spine Deformities. Spine (Phila Pa 1976). 1999;24(18):1903–8.
- 30. Noonan KJ, Dolan LA, Jacobson WC, Weinstein SL. Long-term psychosocial characteristics of patients treated for idiopathic scoliosis. J Pediatr Orthop. 1997;17(6):712–7. pmid:9591971
- 31. Odermatt D, Mathieu PA, Beausejour M, Labelle H, Aubin CE. Electromyography of scoliotic patients treated with a brace. J Orthop Res. 2003;21(5):931–6. pmid:12919883
- 32. Ugwonali OF, Lomas G, Choe JC, Hyman JE, Lee FY, Vitale MG, et al. Effect of bracing on the quality of life of adolescents with idiopathic scoliosis. Spine J. 2004;4(3):254–60. pmid:15125845
- 33. Vasiliadis E, Grivas TB, Savvidou O, Triantafyllopoulos G. The influence of brace on quality of life of adolescents with idiopathic scoliosis. Stud Health Technol Inform. 2006;123:352–6. pmid:17108451
- 34. Weinstein SL, Ponseti IV. Curve progression in idiopathic scoliosis. The Journal of bone and joint surgery American volume. 1983;65(4):447–55. Epub 1983/04/01. pmid:6833318
- 35. Tones M, Moss N, Polly DW Jr. A review of quality of life and psychosocial issues in scoliosis. Spine. 2006;31(26):3027–38. Epub 2006/12/19. pmid:17173000
- 36. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Medical care. 1989;27(3 Suppl):S217–32. Epub 1989/03/01. pmid:2646490
- 37. Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest. 1998;114(4):998–1007. Epub 1998/10/29. pmid:9792568
- 38. Earnshaw J, Lewis G. NICE Guide to the Methods of Technology Appraisal: pharmaceutical industry perspective. PharmacoEconomics. 2008;26(9):725–7. Epub 2008/09/05. pmid:18767892
- 39. Brooks R. EuroQol: the current state of play. Health policy (Amsterdam, Netherlands). 1996;37(1):53–72. Epub 1996/06/06.
- 40. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health economics. 2004;13(12):1203–10. Epub 2004/09/24. pmid:15386669
- 41. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2013;22(7):1717–27. Epub 2012/11/28. PubMed Central PMCID: PMCPmc3764313.
- 42. Longworth L, Rowen D. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2013;16(1):202–10. Epub 2013/01/23.
- 43. Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25. pmid:19585162